Clinical Trial

Feasibility/Acceptability of Attentional-Control Training in Survivors

Study acronym: FAACTS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 10, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter pilot randomized controlled trial, with an active control condition, of the feasibility, acceptability, and preliminary efficacy of EndeavorRx in a cohort of survivors of acute lymphoblastic leukemia or brain tumor ages 8-16 who are \> 1 year from the end of therapy.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-09-01; most recent amendment 2025-01-08.
Status change: Not Yet Recruiting → Recruiting 2023-06-23
Trial Details
NCT Number NCT05528939
Lead Sponsor Children's National Research Institute
Collaborators: St. Jude Children's Research Hospital, Children's Hospital of Philadelphia, George Washington University, National Cancer Institute (NCI)
Conditions Pediatric Cancer, Pediatric ALL, Pediatric Brain Tumor, Attention Difficulties, Cognitive Deficit in Attention
Enrollment 50 participants
Start Date 2023-06-14
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-10